Travere Therapeutics, Inc. (TVTX)
Company Info
Highlights
$2.03B
-$4.52
$158.39M
$142.85M
-$220.34M
$5.12 - $25.29
$32.27
12.16%
7.63
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Travere Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Travere Therapeutics, Inc. had a return of 33.93% year-to-date (YTD) and 181.76% in the last 12 months. Over the past 10 years, Travere Therapeutics, Inc. had an annualized return of 4.88%, while the S&P 500 had an annualized return of 11.31%, indicating that Travere Therapeutics, Inc. did not perform as well as the benchmark.
TVTX
33.93%
27.00%
168.47%
181.76%
6.21%
4.88%
^GSPC (Benchmark)
4.46%
2.46%
9.31%
23.49%
13.03%
11.31%
Monthly Returns
The table below presents the monthly returns of TVTX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 17.45% | 33.93% | |||||||||||
| 2024 | -0.67% | -15.34% | 1.98% | -28.27% | 34.18% | 10.78% | 16.06% | -0.73% | 47.73% | 25.09% | 7.49% | -7.39% | 93.77% |
| 2023 | 6.51% | -1.07% | 1.49% | -4.09% | -17.06% | -14.14% | 11.91% | -16.93% | -37.39% | -27.52% | -3.09% | 43.15% | -57.25% |
| 2022 | -11.40% | -0.87% | -5.47% | -2.48% | -7.24% | 3.95% | -2.85% | 13.68% | -7.92% | -12.01% | -7.15% | 4.47% | -32.25% |
| 2021 | -7.36% | 22.06% | -18.98% | -1.00% | -38.63% | -3.82% | -5.76% | 58.76% | 11.09% | 18.80% | -0.90% | 8.72% | 13.89% |
| 2020 | 8.87% | 0.23% | -5.84% | 4.32% | 3.06% | 30.12% | -2.60% | -1.46% | -5.77% | 9.64% | 13.29% | 18.86% | 91.94% |
| 2019 | -4.73% | 4.64% | 0.31% | -15.69% | -2.88% | 8.42% | -1.49% | -36.38% | -7.94% | 3.54% | 15.58% | 2.38% | -37.25% |
| 2018 | 13.48% | 4.64% | -10.63% | 12.25% | 11.59% | -2.68% | 1.39% | 14.65% | -9.34% | -10.69% | -4.36% | -7.78% | 7.40% |
| 2017 | 3.65% | 8.41% | -13.21% | 6.12% | -19.09% | 22.33% | 4.38% | 20.55% | 2.01% | -0.08% | -9.37% | -6.52% | 11.30% |
| 2016 | -22.40% | -4.94% | -4.01% | 0.88% | 29.03% | 0.17% | 0.67% | -10.65% | 39.70% | -15.77% | 8.59% | -7.52% | -1.87% |
| 2015 | 4.90% | 10.28% | 69.21% | -10.10% | 46.89% | 4.77% | -4.25% | -13.61% | -26.11% | -5.58% | 16.83% | -13.69% | 57.60% |
| 2014 | 51.14% | 67.01% | 19.98% | -32.59% | 2.31% | -19.70% | -9.54% | 28.81% | -34.06% | 7.32% | 4.34% | 21.19% | 74.86% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 93, TVTX is among the top 7% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Travere Therapeutics, Inc. (TVTX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Travere Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Travere Therapeutics, Inc. was 85.43%, occurring on Apr 26, 2024. The portfolio has not yet recovered.
The current Travere Therapeutics, Inc. drawdown is 35.37%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -85.43% | Aug 6, 2015 | 2196 | Apr 26, 2024 | — | — | — |
| -65.37% | Apr 3, 2014 | 161 | Nov 19, 2014 | 88 | Mar 30, 2015 | 249 |
| -62.29% | Dec 18, 2012 | 8 | Dec 28, 2012 | 85 | May 3, 2013 | 93 |
| -48.63% | May 13, 2013 | 53 | Aug 6, 2013 | 104 | Jan 10, 2014 | 157 |
| -46.81% | Dec 12, 2012 | 1 | Dec 12, 2012 | 1 | Dec 17, 2012 | 2 |
Volatility
Volatility Chart
The current Travere Therapeutics, Inc. volatility is 18.23%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Travere Therapeutics, Inc..
Loading data...
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |